ClinicalTrialsFinder

CLDN18.2 Positive Clinical Trials in Hefei, Anhui

1 recruitingHefei, Anhui, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

An Early Clinical Study to Evaluate the Safety and Efficacy of CLDN18.2 CAR T Cell Injection in Subjects With CLDN18.2-Positive Advanced Malignant Solid Tumors

CLDN18.2 Positive Solid Tumors
Celest Therapeutics (Shanghai) Co., Ltd.18 enrolled1 locationNCT07680257